Haffty, Bruce G

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010) · Nature Structural & Molecular Biology

DNA Repair MechanismsBRCA gene mutations in cancer

Cited by 1,001

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer

Pierce, L. J., Levin, A. M., Rebbeck, T. R., Ben-David, M. A., Friedman, E., Solin, L. J., Harris, E. E., Gaffney, D. K., Haffty, B. G., Dawson, L. A., et al. (2006) · Journal of Clinical Oncology

BRCA gene mutations in cancerBreast Cancer Treatment Studies

Cited by 340

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

Haffty, B. G., Harrold, E., Khan, A. J., Pathare, P., Smith, T. E., Turner, B. C., Glazer, P. M., Ward, B., Carter, D., Matloff, E., et al. (2002) · The Lancet

BRCA gene mutations in cancerMultiple and Secondary Primary Cancers

Cited by 307

Borderline ER-positive primary breast cancer gains no significant survival benefit from endocrine therapy: a systematic review and meta-analysis

Chen, T., Zhang, N., Moran, M. S., Su, P., Haffty, B. G., & Yang, Q. (2018) · Clinical Breast Cancer

Breast Cancer Treatment StudiesEstrogen and related hormone effects

Cited by 94

Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation

Schonewolf, C. A., Mehta, M., Schiff, D., Wu, H., Haffty, B. G., Karantza, V., & Jabbour, S. K. (2014) · World Journal of Gastrointestinal Oncology

Autophagy in Disease and TherapyCancer, Hypoxia, and Metabolism

Cited by 71